Topic Hub

Ethnicity Suvorexant

4 clinically reviewed articles, written and peer-reviewed by the HealthRX Medical Team.

4articles

32keywords mapped

2026-05-27latest review

Explore

Ethnicity Suvorexant library

Showing 4 of 4 clinical reviews.

Clinical Reviews2026-05-27

Belsomra (Suvorexant) in South Asian Patients: Documented Efficacy Gaps and Pharmacogenomic Considerations

Evidence review of suvorexant (Belsomra) efficacy in South Asian populations, covering CYP3A4 pharmacogenomics, BMI-adjusted dosing, and ethnicity-stratified trial data.

Read clinical review

Safety2026-05-27

Belsomra (Suvorexant) Safety Profile Differences in Black / African Ancestry Patients

Evidence-based review of suvorexant (Belsomra) pharmacogenomics, dosing considerations, and safety data relevant to Black and African ancestry populations.

Read clinical review

Safety2026-05-27

Belsomra (Suvorexant) Safety Profile Differences in Hispanic / Latino Patients

Evidence-based review of suvorexant pharmacogenomics, CYP3A4 metabolism, and dosing considerations specific to Hispanic and Latino populations, including diabetes comorbidity data and ethnicity-stratified trial results.

Read clinical review

Safety2026-05-27

Belsomra (Suvorexant) Safety Profile Differences in South Asian Patients

Evidence-based review of how suvorexant (Belsomra) safety, metabolism, and dosing may differ in South Asian populations due to pharmacogenomic variation, body composition, and CYP3A4 polymorphisms.

Read clinical review